Literature DB >> 9716941

Caffeine--an atypical drug of dependence.

J W Daly1, B B Fredholm.   

Abstract

Caffeine has both positive effects that contribute to widespread consumption of caffeine-containing beverages and adverse unpleasant effects if doses are increased. Caffeine has weak reinforcing properties, but with little or no evidence for upward dose adjustment, possibly because of the adverse effects of higher doses. Withdrawal symptoms, although relatively limited with respect to severity, do occur, and may contribute to maintenance of caffeine consumption. Health hazards are small if any and caffeine use is not associated with incapacitation. Thus, although caffeine can be argued to fulfill regulatory criteria as a dependence-producing drug, the extensive use of caffeine-containing beverages poses little apparent risk to the consumer or to society. The positive stimulatory effects of caffeine appear in large measure to be due to blockade of A2A receptors that stimulate GABAergic neurons of inhibitory pathways to the dopaminergic reward system of the striatum. However, blockade of striatal A1 receptors may also play a role. The mechanisms underlying negative effects of higher doses of caffeine are as yet not well defined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716941     DOI: 10.1016/s0376-8716(98)00077-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  50 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

3.  Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum.

Authors:  Luara A Batista; Thércia G Viana; Vívian T Silveira; Daniele C Aguiar; Fabrício A Moreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-29       Impact factor: 3.000

4.  A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.

Authors:  Katerina Antoniou; Zeta Papadopoulou-Daifoti; Thomas Hyphantis; Georgia Papathanasiou; Efstathios Bekris; Marios Marselos; Leigh Panlilio; Christa E Müller; Steven R Goldberg; Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

5.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

6.  Caffeine, a common active adulterant of cocaine, enhances the reinforcing effect of cocaine and its motivational value.

Authors:  José Pedro Prieto; Cecilia Scorza; Gian Pietro Serra; Valentina Perra; Martín Galvalisi; Juan Andrés Abin-Carriquiry; Giovanna Piras; Valentina Valentini
Journal:  Psychopharmacology (Berl)       Date:  2016-06-07       Impact factor: 4.530

7.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

Review 8.  Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2011-07-18       Impact factor: 3.455

9.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

10.  Caffeine dose effect on activation-induced BOLD and CBF responses.

Authors:  Yufen Chen; Todd B Parrish
Journal:  Neuroimage       Date:  2009-03-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.